£80.66

Springer Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)

Price data updated today

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£81 today · previous high £81 · all-time low £80

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 91 days • 91 data points

Historical
Generating forecast...
£80.66 £79.86 £80.03 £80.21 £80.38 £80.56 £80.73 05 April 2026 27 April 2026 20 May 2026 11 June 2026 04 July 2026

Price Distribution

Price distribution over 91 days • 2 price levels

Days at Price
Current Price
21 days 70 days · current 0 18 35 53 70 £80 £81 Days at Price

Price Analysis

Most common price: £81 (70 days, 76.9%)

Price range: £80 - £81

Price levels: 2 different prices over 91 days

Description

from combining radiation with a molecular targeted agent – namely cetuximab, a recombinant mouse/human chimeric monoclonal antibody against the Epidermal Growth Factor (EGF) receptor [4] Astsaturov, Cohen and Harari present a more indepth review of the biology of the EGF Receptor and its signaling pathway in Chap. 7 as a potential target in combination with fractionated radiotherap y for head and neck squamous cell carcinoma (HNSCC). A flurry of agents are under de velopment for targeting EGFR and in March 2006, the US Food and Drugs Administration approved cetuximab combined with radiation as a primary treatment option for patients with loco-regionally advanced HNSCC in whom chemoradiation therapy is deemed not to be an option. While blocking the EGF pathway during fractionated radiotherapy may seem an obvious strategy [5], the rationale for combining antiangiogenic and antivascular targeting agents with radiation may be less intuitive. However, recent research shows that there are several reasons why this could result in a therapeutic gain in practice. Chapter 8 is a review of this rapidly expanding field by Citrin and Camphausen. Targeted agents combined with radiation may offer new opportunities in the treatment of central nervous system malignancies, a tumor type where the outlook remains poor despite some recent progress [6]. Current attempts to overcome rad- tion resistance in these tumors on the basis of an improved understanding of their molecular biology are the topic of Chap. 9 by Chakravarti and Palanichamy.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 November 2010
Listed Since
01 October 2010

Barcode

No barcode data available

Similar Products You Might Like

Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)
100% match

Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)

Springer

£84.32 03 Jul 2026
Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)
81% match

Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)

Springer

£53.53 16 May 2026
Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)
80% match

Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)

Humana

£104.85 29 May 2026
Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)
80% match

Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)

Springer

£77.58 03 Jun 2026
Radiation Therapy for Head and Neck Cancers: A Case-Based Review
80% match

Radiation Therapy for Head and Neck Cancers: A Case-Based Review

Springer

£68.90 17 May 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
79% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£113.94 01 Jun 2026
Radiotherapy in Managing Brain Metastases: A Case-Based Approach
79% match

Radiotherapy in Managing Brain Metastases: A Case-Based Approach

Springer

£73.10 05 Jun 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
78% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£130.93 20 May 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
78% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.64 25 May 2026
Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management
78% match

Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management

Springer

£88.17 05 Jun 2026
Thermoradiotherapy and Thermochemotherapy: Biology, Physiology, Physics (Medical Radiology)
78% match

Thermoradiotherapy and Thermochemotherapy: Biology, Physiology, Physics (Medical Radiology)

Springer

£176.18 24 Jun 2026
Chemotherapy and Radiotherapy of Gastrointestinal Tumors: 79 (Recent Results in Cancer Research, 79)
78% match

Chemotherapy and Radiotherapy of Gastrointestinal Tumors: 79 (Recent Results in Cancer Research, 79)

Springer

£77.42 03 Jul 2026
Oncology of CNS Tumors
78% match

Oncology of CNS Tumors

Springer

£179.99 26 May 2026
Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)
78% match

Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)

Springer

£11.80 01 Jun 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
78% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.39 26 May 2026
Radiation Treatment and Radiation Reactions in Dermatology
78% match

Radiation Treatment and Radiation Reactions in Dermatology

Springer

£109.99 06 Jun 2026
Soft Tissue Sarcomas: Present Achievements and Future Prospects: 91 (Cancer Treatment and Research, 91)
78% match

Soft Tissue Sarcomas: Present Achievements and Future Prospects: 91 (Cancer Treatment and Research, 91)

Springer

£163.78 13 Jun 2026
Brain Tumor Immunotherapy
77% match

Brain Tumor Immunotherapy

Humana

£129.72 03 Jun 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
77% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£74.57 05 Jun 2026
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (Imaging in Medical Diagnosis and Therapy)
77% match

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (Imaging in Medical Diagnosis and Therapy)

CRC Press

£73.44 01 Jul 2026
Functional Preservation and Quality of Life in Head and Neck Radiotherapy (Medical Radiology)
77% match

Functional Preservation and Quality of Life in Head and Neck Radiotherapy (Medical Radiology)

Springer

£102.67 30 Jun 2026
Radiation Therapy for Pelvic Malignancy and its Consequences
77% match

Radiation Therapy for Pelvic Malignancy and its Consequences

Springer

£66.80 18 May 2026
Robotic Radiosurgery. Treating Tumors that Move with Respiration
77% match

Robotic Radiosurgery. Treating Tumors that Move with Respiration

Springer

£81.58 28 May 2026
Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)
77% match

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Springer

£148.53 26 May 2026